56 related articles for article (PubMed ID: 32088803)
1. Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision.
Zaffaroni G; Mannucci A; Koskenvuo L; de Lacy B; Maffioli A; Bisseling T; Half E; Cavestro GM; Valle L; Ryan N; Aretz S; Brown K; Buttitta F; Carneiro F; Claber O; Blanco-Colino R; Collard M; Crosbie E; Cunha M; Doulias T; Fleming C; Heinrich H; Hüneburg R; Metras J; Nagtegaal I; Negoi I; Nielsen M; Pellino G; Ricciardiello L; Sagir A; Sánchez-Guillén L; Seppälä TT; Siersema P; Striebeck B; Sampson JR; Latchford A; Parc Y; Burn J; Möslein G
Br J Surg; 2024 May; 111(5):. PubMed ID: 38722804
[TBL] [Abstract][Full Text] [Related]
2. Risk of gastric adenoma and adenocarcinoma in patients with familial adenomatous polyposis in Japan: a nationwide multicenter study.
Sasaki K; Kawai K; Nozawa H; Ishihara S; Ishida H; Ishibashi K; Mori Y; Shichijo S; Tani Y; Takeuchi Y; Chino A; Takao M; Fujiyoshi K; Matsubara T; Miyakura Y; Taniguchi F; Yamaguchi T; Tanakaya K; Tomita N; Ajioka Y
J Gastroenterol; 2024 Mar; 59(3):187-194. PubMed ID: 38263336
[TBL] [Abstract][Full Text] [Related]
3. PIGA mutations and glycosylphosphatidylinositol anchor dysregulation in polyposis-associated duodenal tumorigenesis.
Meuser E; Chang K; Walters A; Hurley JJ; West HD; Perry I; Mort M; Reyes-Uribe L; Truscott R; Jones N; Lawrence R; Jenkins G; Giles P; Dolwani S; Al-Sarireh B; Hawkes N; Short E; Williams GT; Taggart MW; Luetchford K; Lynch PM; Terlouw D; Nielsen M; Walton SJ; Latchford A; Clark SK; Sampson JR; Vilar E; Thomas LE
Mol Cancer Res; 2024 Mar; ():. PubMed ID: 38546397
[TBL] [Abstract][Full Text] [Related]
4. Phenotype correlations with pathogenic DNA variants in the
Thet M; Plazzer JP; Capella G; Latchford A; Nadeau EA; Greenblatt MS; Macrae F
medRxiv; 2024 May; ():. PubMed ID: 38798681
[No Abstract] [Full Text] [Related]
5. MUTYH-associated tumor syndrome: The other face of MAP.
Magrin L; Fanale D; Brando C; Corsini LR; Randazzo U; Di Piazza M; Gurrera V; Pedone E; Bazan Russo TD; Vieni S; Pantuso G; Russo A; Bazan V
Oncogene; 2022 Apr; 41(18):2531-2539. PubMed ID: 35422474
[TBL] [Abstract][Full Text] [Related]
6. Adenomas arising in Barrett's esophagus with adenocarcinoma. Report of three cases.
Paraf F; Fléjou JF; Potet F; Molas G; Fékété F
Pathol Res Pract; 1992 Dec; 188(8):1028-32. PubMed ID: 1300598
[TBL] [Abstract][Full Text] [Related]
7. The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP).
Claes K; Dahan K; Tejpar S; De Paepe A; Bonduelle M; Abramowicz M; Verellen C; Franchimont D; Van Cutsem E; Kartheuser A
Acta Gastroenterol Belg; 2011 Sep; 74(3):421-6. PubMed ID: 22103048
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of Barrett's esophagus in patients with MUTYH-associated polyposis (MAP).
Daans CG; Ghorbanoghli Z; Velthuizen ME; Vasen HFA; Offerhaus GJA; Lacle MM; Siersema PD; Ausems MGEM; Boonstra JJ
Fam Cancer; 2020 Apr; 19(2):183-187. PubMed ID: 32088803
[TBL] [Abstract][Full Text] [Related]
9. Barrett's esophagus in the patients with familial adenomatous polyposis.
Gatalica Z; Chen M; Snyder C; Mittal S; Lynch HT
Fam Cancer; 2014 Jun; 13(2):213-7. PubMed ID: 23771323
[TBL] [Abstract][Full Text] [Related]
10. The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis.
Hurley JJ; Thomas LE; Walton SJ; Thomas-Gibson S; Haycock A; Suzuki N; Mort M; Williams G; Morgan M; Clark SK; Sampson JR; Dolwani S
Gastrointest Endosc; 2018 Oct; 88(4):665-673. PubMed ID: 29702101
[TBL] [Abstract][Full Text] [Related]
11. Burden and Profile of Somatic Mutation in Duodenal Adenomas from Patients with Familial Adenomatous- and
Thomas LE; Hurley JJ; Meuser E; Jose S; Ashelford KE; Mort M; Idziaszczyk S; Maynard J; Brito HL; Harry M; Walters A; Raja M; Walton SJ; Dolwani S; Williams GT; Morgan M; Moorghen M; Clark SK; Sampson JR
Clin Cancer Res; 2017 Nov; 23(21):6721-6732. PubMed ID: 28790112
[No Abstract] [Full Text] [Related]
12. Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.
Papp J; Kovacs ME; Matrai Z; Orosz E; Kásler M; Børresen-Dale AL; Olah E
Fam Cancer; 2016 Jan; 15(1):85-97. PubMed ID: 26446593
[TBL] [Abstract][Full Text] [Related]
13. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
Nielsen M; Hes FJ; Nagengast FM; Weiss MM; Mathus-Vliegen EM; Morreau H; Breuning MH; Wijnen JT; Tops CM; Vasen HF
Clin Genet; 2007 May; 71(5):427-33. PubMed ID: 17489848
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort.
Hardikar S; Onstad L; Song X; Wilson AM; Montine TJ; Kratz M; Anderson GL; Blount PL; Reid BJ; White E; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2393-403. PubMed ID: 25106775
[TBL] [Abstract][Full Text] [Related]
15. Higher prevalence of colon polyps in patients with Barrett's esophagus: a case-control study.
Kumaravel A; Thota PN; Lee HJ; Gohel T; Kanadiya MK; Lopez R; Sanaka MR
Gastroenterol Rep (Oxf); 2014 Nov; 2(4):281-7. PubMed ID: 25085954
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
